Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma.
Decock A, Ongenaert M, Cannoodt R, Verniers K, De Wilde B, Laureys G, Van Roy N, Berbegall AP, Bienertova-Vasku J, Bown N, Clément N, Combaret V, Haber M, Hoyoux C, Murray J, Noguera R, Pierron G, Schleiermacher G, Schulte JH, Stallings RL, Tweddle DA; Children’s Cancer and Leukaemia Group (CCLG); De Preter K, Speleman F, Vandesompele J. Decock A, et al. Among authors: combaret v. Oncotarget. 2016 Jan 12;7(2):1960-72. doi: 10.18632/oncotarget.6477. Oncotarget. 2016. PMID: 26646589 Free PMC article.
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lacking MYCN amplification.
Plantaz D, Vandesompele J, Van Roy N, Lastowska M, Bown N, Combaret V, Favrot MC, Delattre O, Michon J, Bénard J, Hartmann O, Nicholson JC, Ross FM, Brinkschmidt C, Laureys G, Caron H, Matthay KK, Feuerstein BG, Speleman F. Plantaz D, et al. Among authors: combaret v. Int J Cancer. 2001 Mar 1;91(5):680-6. doi: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1114>3.0.co;2-r. Int J Cancer. 2001. PMID: 11267980
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there?
Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, Combaret V, Delattre O, Feuerstein BG, Plantaz D. Vandesompele J, et al. Among authors: combaret v. Med Pediatr Oncol. 2001 Jan;36(1):5-10. doi: 10.1002/1096-911X(20010101)36:1<5::AID-MPO1003>3.0.CO;2-E. Med Pediatr Oncol. 2001. PMID: 11464905
Quality assessment of genetic markers used for therapy stratification.
Ambros IM, Benard J, Boavida M, Bown N, Caron H, Combaret V, Couturier J, Darnfors C, Delattre O, Freeman-Edward J, Gambini C, Gross N, Hattinger CM, Luegmayr A, Lunec J, Martinsson T, Mazzocco K, Navarro S, Noguera R, O'Neill S, Potschger U, Rumpler S, Speleman F, Tonini GP, Valent A, Van Roy N, Amann G, De Bernardi B, Kogner P, Ladenstein R, Michon J, Pearson AD, Ambros PF. Ambros IM, et al. Among authors: combaret v. J Clin Oncol. 2003 Jun 1;21(11):2077-84. doi: 10.1200/JCO.2003.03.025. J Clin Oncol. 2003. PMID: 12775732
Variety and complexity of chromosome 17 translocations in neuroblastoma.
Schleiermacher G, Raynal V, Janoueix-Lerosey I, Combaret V, Aurias A, Delattre O. Schleiermacher G, et al. Among authors: combaret v. Genes Chromosomes Cancer. 2004 Feb;39(2):143-50. doi: 10.1002/gcc.10313. Genes Chromosomes Cancer. 2004. PMID: 14695994
No evidence for involvement of SDHD in neuroblastoma pathogenesis.
De Preter K, Vandesompele J, Hoebeeck J, Vandenbroecke C, Smet J, Nuyts A, Laureys G, Combaret V, Van Roy N, Roels F, Van Coster R, Praet M, De Paepe A, Speleman F. De Preter K, et al. Among authors: combaret v. BMC Cancer. 2004 Aug 24;4:55. doi: 10.1186/1471-2407-4-55. BMC Cancer. 2004. PMID: 15331017 Free PMC article.
138 results